Perkins Capital Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.11M | Hold |
9,700
| – | – | 3.84% | 8 |
|
|
2026
Q1 | $5.45M | Hold |
9,700
| – | – | 5.11% | 4 |
|
|
2025
Q4 | $6.56M | Hold |
9,700
| – | – | 5.21% | 4 |
|
|
2025
Q3 | $6.2M | Hold |
9,700
| – | – | 5.46% | 5 |
|
|
2025
Q2 | $5.2M | Hold |
9,700
| – | – | 5.23% | 4 |
|
|
2025
Q1 | $4.07M | Hold |
9,700
| – | – | 4.3% | 5 |
|
|
2024
Q4 | $4.01M | Hold |
9,700
| – | – | 3.56% | 6 |
|
|
2024
Q3 | $4.9M | Sell |
9,700
-800
| -8% | -$389K | 4.6% | 4 |
|
|
2024
Q2 | $5.12M | Hold |
10,500
| – | – | 4.82% | 4 |
|
|
2024
Q1 | $5.67M | Hold |
10,500
| – | – | 4.73% | 4 |
|
|
2023
Q4 | $5.83M | Sell |
10,500
-305
| -3% | -$143K | 4.98% | 3 |
|
|
2023
Q3 | $4.72M | Hold |
10,805
| – | – | 4.68% | 4 |
|
|
2023
Q2 | $5.43M | Hold |
10,805
| – | – | 4.73% | 3 |
|
|
2023
Q1 | $5.4M | Hold |
10,805
| – | – | 5.09% | 1 |
|
|
2022
Q4 | $4.41M | Hold |
10,805
| – | – | 4.65% | 2 |
|
|
2022
Q3 | $3.52M | Hold |
10,805
| – | – | 3.94% | 5 |
|
|
2022
Q2 | $3.79M | Hold |
10,805
| – | – | 3.92% | 3 |
|
|
2022
Q1 | $5.91M | Hold |
10,805
| – | – | 4.85% | 1 |
|
|
2021
Q4 | $7.12M | Sell |
10,805
-300
| -3% | -$188K | 4.8% | 1 |
|
|
2021
Q3 | $6.91M | Hold |
11,105
| – | – | 4.28% | 4 |
|
|
2021
Q2 | $7.01M | Hold |
11,105
| – | – | 3.98% | 5 |
|
|
2021
Q1 | $5.43M | Hold |
11,105
| – | – | 3.14% | 8 |
|
|
2020
Q4 | $5.55M | Sell |
11,105
-100
| -0.9% | -$44.7K | 3.63% | 7 |
|
|
2020
Q3 | $4.41M | Buy |
+11,205
| New | +$4.14M | 4.05% | 5 |
|
|
2020
Q1 | $2.71M | Sell |
11,205
-145
| -1% | -$37.8K | 3.28% | 5 |
|
|
2019
Q4 | $2.96M | Hold |
11,350
| – | – | 2.66% | 5 |
|
|
2019
Q3 | $3.09M | Hold |
11,350
| – | – | 2.66% | 7 |
|
|
2019
Q2 | $3.13M | Sell |
11,350
-2,000
| -15% | -$493K | 2.19% | 12 |
|
|
2019
Q1 | $2.98M | Hold |
13,350
| – | – | 1.97% | 11 |
|
|
2018
Q4 | $2.48M | Hold |
13,350
| – | – | 1.93% | 12 |
|
|
2018
Q3 | $3.33M | Hold |
13,350
| – | – | 2% | 6 |
|
|
2018
Q2 | $2.91M | Hold |
13,350
| – | – | 2.08% | 5 |
|
|
2018
Q1 | $2.56M | Hold |
13,350
| – | – | 2.3% | 4 |
|
|
2017
Q4 | $2.09M | Sell |
13,350
-650
| -5% | -$102K | 2.01% | 8 |
|
|
2017
Q3 | $2.18M | Hold |
14,000
| – | – | 2.28% | 8 |
|
|
2017
Q2 | $2.26M | Hold |
14,000
| – | – | 2.51% | 8 |
|
|
2017
Q1 | $2.17M | Hold |
14,000
| – | – | 2.23% | 9 |
|
|
2016
Q4 | $1.64M | Hold |
14,000
| – | – | 1.8% | 12 |
|
|
2016
Q3 | $1.58M | Hold |
14,000
| – | – | 1.58% | 16 |
|
|
2016
Q2 | $1.3M | Hold |
14,000
| – | – | 1.49% | 15 |
|
|
2016
Q1 | $1.1M | Hold |
14,000
| – | – | 1.37% | 23 |
|
|
2015
Q4 | $1.02M | Hold |
14,000
| – | – | 1.1% | 28 |
|
|
2015
Q3 | $1.04M | Hold |
14,000
| – | – | 1.16% | 25 |
|
|
2015
Q2 | $898K | Hold |
14,000
| – | – | 0.79% | 43 |
|
|
2015
Q1 | $1.08M | Hold |
14,000
| – | – | 0.91% | 38 |
|
|
2014
Q4 | $1.04M | Hold |
14,000
| – | – | 0.89% | 44 |
|
|
2014
Q3 | $825K | Hold |
14,000
| – | – | 0.7% | 57 |
|
|
2014
Q2 | $935K | Hold |
14,000
| – | – | 0.66% | 53 |
|
|
2014
Q1 | $850K | Hold |
14,000
| – | – | 0.6% | 60 |
|
|
2013
Q4 | $745K | Hold |
14,000
| – | – | 0.5% | 71 |
|
|
2013
Q3 | $698K | Buy |
+14,000
| New | +$673K | 0.5% | 71 |
|
Other funds holding IDXX
Perkins Capital Management's IDXX Position: Q2 2026 in Review
Perkins Capital Management held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 9,700 shares worth $5.11M. The position accounts for 3.84% of the portfolio, ranked #8.
Perkins Capital Management first reported a position in IDXX in Q3 2013 and has held it in 51 quarters since. The position peaked at $7.12M in Q4 2021. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Perkins Capital Management held 9,700 shares of Idexx Laboratories worth $5.11M as of Q2 2026.
- Perkins Capital Management left its Idexx Laboratories share count unchanged in Q2 2026.
- Idexx Laboratories made up 3.84% of Perkins Capital Management's portfolio in Q2 2026, its #8 holding.
- Perkins Capital Management first reported a position in Idexx Laboratories in Q3 2013 and has held it in 51 quarters since.
- Perkins Capital Management's Idexx Laboratories position peaked at $7.12M in Q4 2021.
- 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Perkins Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.